$NIXX
Nixxy, Inc. Stock $nixx

$nixx Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000165495423004101 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$3.293M	$4.424M	$25.37M
YoY Change	-52.06%	-47.22%	14.37%
Cost Of Revenue	$2.555M	$3.487M	$16.62M
YoY Change	-38.84%	-39.41%	11.5%
Gross Profit	$737.3K	$936.6K	$8.748M
YoY Change	-72.6%	-64.34%	20.25%
Gross Profit Margin	22.39%	21.17%	34.48%
Selling, General & Admin	$2.991M	$2.521M	$16.05M
YoY Change	-42.65%	-64.16%	-9.81%
% of Gross Profit	405.62%	269.14%	183.49%
Research & Development	$242.3K	$208.2K	$1.359M
YoY Change	-59.17%	-61.56%	17.9%
% of Gross Profit	32.86%	22.23%	15.53%
Depreciation & Amortization	$307.7K	$782.0K	$3.650M
YoY Change	106379.58%	-26.51%	316209.01%
% of Gross Profit	41.74%	83.49%	41.73%
Operating Expenses	$3.541M	$3.501M	$25.48M
YoY Change	-48.06%	-59.47%	5.2%
Operating Profit	-$2.803M	-$2.565M	-$16.73M
YoY Change	-32.05%	-57.35%	-1.25%
Interest Expense	$514.2K	-$625.1K	$965.3K
YoY Change	662.67%	-1323.47%	-16.24%
% of Operating Profit
Other Income/Expense, Net	$1.790K	$3.990K	$257.8K
YoY Change	-103.16%	-86.33%	-57.76%
Pretax Income	-$3.316M	-$5.477M	-$16.47M
YoY Change	-20.72%	-7.68%	65997.04%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.316M	-$6.740M	-$16.47M
YoY Change	-20.72%	13.61%	0.86%
Net Earnings / Revenue	-100.7%	-152.37%	-64.93%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.23	-$0.42	-$1.22
COMMON SHARES
Basic Shares Outstanding	17.21M shares	16.28M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$238.2K	$946.8K	$946.8K
YoY Change	-73.78%	-63.36%	-63.36%
Cash & Equivalents	$238.2K	$946.8K
Short-Term Investments		$0.00
Other Short-Term Assets	$333.8K	$252.7K	$252.7K
YoY Change	-21.43%	-53.73%	-53.73%
Inventory
Prepaid Expenses	$152.8K	$40.86K
Receivables	$1.988M	$3.190M	$3.190M
Other Receivables	$14.40K	$2.880K	$2.880K
Total Short-Term Assets	$2.574M	$4.392M	$4.392M
YoY Change	-58.5%	-50.26%	-50.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$55.08K	$61.34K	$61.34K
YoY Change	28588.54%	12652.6%	12679.17%
Goodwill	$7.101M	$7.101M
YoY Change	-7.58%	-8.0%
Intangibles	$2.271M	$2.579M
YoY Change	-74.0%	-73.53%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$9.427M	$9.741M	$9.741M
YoY Change	-42.58%	-44.21%	-44.21%
TOTAL ASSETS
Total Short-Term Assets	$2.574M	$4.392M	$4.392M
Total Long-Term Assets	$9.427M	$9.741M	$9.741M
Total Assets	$12.00M	$14.13M	$14.13M
YoY Change	-46.94%	-46.24%	-46.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.761M	$1.570M	$1.570M
YoY Change	47.44%	39.97%	22.15%
Accrued Expenses	$870.0K	$911.4K	$1.406M
YoY Change	-59.35%	-68.98%	-52.13%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.947M	$3.701M	$3.701M
YoY Change	121.58%	116.12%	116.12%
Total Short-Term Liabilities	$8.355M	$7.795M	$7.795M
YoY Change	22.8%	3.06%	3.06%
LONG-TERM LIABILITIES
Long-Term Debt	$1.026M	$1.260M	$1.260M
YoY Change	-50.92%	-52.22%	-52.22%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$1.026M	$1.260M	$1.260M
YoY Change	-50.92%	-52.22%	-52.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.355M	$7.795M	$7.795M
Total Long-Term Liabilities	$1.026M	$1.260M	$1.260M
Total Liabilities	$9.381M	$9.055M	$9.055M
YoY Change	5.48%	-11.23%	-11.23%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.07M	-$69.26M
YoY Change	32.76%	36.17%
Common Stock	$1.722K	$1.629K
YoY Change	16.43%	11.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.621M	$5.078M	$5.078M
YoY Change
Total Liabilities & Shareholders Equity	$12.00M	$14.13M	$14.13M
YoY Change	-46.94%	-46.24%	-46.24%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$3.316M	-$6.740M	-$16.47M
YoY Change	-20.72%	13.61%	0.86%
Depreciation, Depletion And Amortization	$307.7K	$782.0K	$3.650M
YoY Change	106379.58%	-26.51%	316209.01%
Cash From Operating Activities	-$1.528M	-$2.291M	-$6.948M
YoY Change	27.76%	12.86%	-22.93%
INVESTING ACTIVITIES
Capital Expenditures		$1.570K	$74.61K
YoY Change
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities		$1.050M	-$275.5K
YoY Change		-735.25%	-87.7%
Cash From Investing Activities	$0.00	$1.048M	-$350.1K
YoY Change		-734.3%	-84.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$819.5K	2.181M	$5.661M
YoY Change	-270.9%	-484.31%	-58.79%
NET CHANGE
Cash From Operating Activities	-$1.528M	-2.291M	-$6.948M
Cash From Investing Activities	$0.00	1.048M	-$350.1K
Cash From Financing Activities	$819.5K	2.181M	$5.661M
Net Change In Cash	-$708.6K	938.3K	-$1.637M
YoY Change	-57.71%	-133.96%	-165.91%
FREE CASH FLOW
Cash From Operating Activities	-$1.528M	-$2.291M	-$6.948M
Capital Expenditures		$1.570K	$74.61K
Free Cash Flow		-$2.293M	-$7.023M
YoY Change		12.94%	-22.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Assets Current AssetsCurrent	8829842	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	481	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2578692	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	9741832	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7718842	usd
CY2021Q4	us-gaap	Assets Assets	26290997	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1121510	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	81576	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	19726	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2484	usd
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	81728	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17333	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	17333	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	3700855	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1712387	usd
CY2022Q4	rcrt	Refundable Deposit On Preferred Stock Purchases RefundableDepositOnPreferredStockPurchases	285000	usd
CY2021Q4	rcrt	Refundable Deposit On Preferred Stock Purchases RefundableDepositOnPreferredStockPurchases	285000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	215219	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	746449	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7794624	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7562897	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	1260343	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	2637875	usd
CY2022Q4	us-gaap	Liabilities Liabilities	9054967	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16277764	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14566420	shares
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001462223
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	dei	Entity Public Float EntityPublicFloat	13292661	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16277764	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14566420	shares
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	0	usd
CY2021Q4	rcrt	Available For Sale Securities And Held To Maturity Security AvailableForSaleSecuritiesAndHeldToMaturitySecurity	42720	usd
CY2022	rcrt	Available For Sale Equity Securities Gross Unrealized Losses AvailableForSaleEquitySecuritiesGrossUnrealizedLosses	42720	usd
CY2021	rcrt	Unamortized Discount To Interest Expense UnamortizedDiscountToInterestExpense	0	usd
CY2021	rcrt	Unamortized Discount Outstanding Amount UnamortizedDiscountOutstandingAmount	0	usd
CY2021	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Warrants Outstanding Reissued Pursuant To Modification ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWarrantsOutstandingReissuedPursuantToModification	522108	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2022	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsCancelled	0	shares
CY2022	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Weighted Average Cancelled ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageCancelled	4.00
CY2021	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021Q4	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice	4.32
CY2021Q2	rcrt	Stock Unit Price Per Share StockUnitPricePerShare	5.00
CY2021Q2	rcrt	Stock Unit Price Per Share StockUnitPricePerShare	5.00
CY2021Q3	rcrt	Stock Unit Price Per Share StockUnitPricePerShare	5.00
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	1275479	usd
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q2	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	71538	usd
CY2021Q1	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	11249	usd
CY2021Q1	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	342808	usd
CY2021Q1	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	13541	usd
CY2021Q2	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	65315	usd
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with a one year cliff, with the first portion vesting on August 26, 2022
CY2021Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	71538	usd
CY2021Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	17549	usd
CY2021Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	428510	usd
CY2021Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	14669	usd
CY2021Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	15988	usd
CY2021Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	8129	usd
CY2021Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	22491	usd
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	0	shares
CY2022	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	0	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-53641
CY2022	dei	Entity Registrant Name EntityRegistrantName	RECRUITER.COM GROUP, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	90-1505893
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 Seventh Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10018
CY2022	dei	City Area Code CityAreaCode	855
CY2022	dei	Local Phone Number LocalPhoneNumber	931-1500
CY2022	dei	Security12b Title Security12bTitle	Common Stock
CY2022	dei	Trading Symbol TradingSymbol	RCRT
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17210085	shares
CY2022	dei	Auditor Firm AuditorFirmId	106
CY2022	dei	Auditor Name AuditorName	SALBERG & COMPANY, P.A
CY2022	dei	Auditor Location AuditorLocation	Boca Raton, Florida
CY2022Q4	us-gaap	Cash Cash	946804	usd
CY2022Q4	rcrt	Accounts Receivable Related Parties Amount AccountsReceivableRelatedPartiesAmount	0	usd
CY2021Q4	rcrt	Accounts Receivable Related Parties Amount AccountsReceivableRelatedPartiesAmount	49033	usd
CY2022Q4	rcrt	Accounts Payable Related Parties AccountsPayableRelatedParties	0	usd
CY2021Q4	rcrt	Accounts Payable Related Parties AccountsPayableRelatedParties	163672	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	911386	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1285339	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	410957	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	1551162	usd
CY2022Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	0	usd
CY2021Q4	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	578591	usd
CY2022Q4	rcrt	Warrant Liability For Puttable Warrants WarrantLiabilityForPuttableWarrants	600000	usd
CY2021Q4	rcrt	Warrant Liability For Puttable Warrants WarrantLiabilityForPuttableWarrants	0	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10200772	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	587945	shares
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	16624690	usd
CY2022	us-gaap	Gross Profit GrossProfit	8747584	usd
CY2021	us-gaap	Gross Profit GrossProfit	7274723	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	725687	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	472213	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1358675	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1152433	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3650206	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2741008	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4420539	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2530325	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15324941	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17323695	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	25480048	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	24219674	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-16732464	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-16944951	usd
CY2022	us-gaap	Interest Expense InterestExpense	965323	usd
CY2021	us-gaap	Interest Expense InterestExpense	3137050	usd
CY2022	rcrt	Initial Derivative Expense InitialDerivativeExpense	0	usd
CY2021	rcrt	Initial Derivative Expense InitialDerivativeExpense	3585983	usd
CY2022	rcrt	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	0	usd
CY2021	rcrt	Change In Fair Value Of Derivative Liabilities ChangeInFairValueOfDerivativeLiabilities	7315580	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1205195	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	24925	usd
CY2022	rcrt	Grant Income GrantIncome	0	usd
CY2021	rcrt	Grant Income GrantIncome	3382	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	0	usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-1424	usd
CY2022	rcrt	Other Expense OtherExpense	-17904	usd
CY2021	rcrt	Other Expense OtherExpense	9094	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	257776	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	610336	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16474688	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16334615	usd
CY2022	us-gaap	Dividends Dividends	1921213	usd
CY2021	us-gaap	Dividends Dividends	0	usd
CY2022	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-18395901	usd
CY2021	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-16334615	usd
CY2022	rcrt	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-1.22
CY2021	rcrt	Net Loss Per Common Share Basic And Diluted NetLossPerCommonShareBasicAndDiluted	-1.90
CY2022	rcrt	Weighted Average Common Shares Basic And Diluted WeightedAverageCommonSharesBasicAndDiluted	15128513	shares
CY2021	rcrt	Weighted Average Common Shares Basic And Diluted WeightedAverageCommonSharesBasicAndDiluted	8601159	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-11124262	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5119118	usd
CY2021	rcrt	Issuance Of Common Shares For Scouted Amount IssuanceOfCommonSharesForScoutedAmount	1625184	usd
CY2021	rcrt	Issuance Of Initial And Earnout Shares For Upsider Acquisition Amount IssuanceOfInitialAndEarnoutSharesForUpsiderAcquisitionAmount	3460334	usd
CY2021	rcrt	Issuance Of Common Shares For Accrued Compensation Amount IssuanceOfCommonSharesForAccruedCompensationAmount	16425	usd
CY2021	rcrt	Issuance Of Common Shares Upon Conversion Of Debentures And Accrued Interest Amount IssuanceOfCommonSharesUponConversionOfDebenturesAndAccruedInterestAmount	4557718	usd
CY2021	rcrt	Cancellation Of Series D Preferred Stock Amount CancellationOfSeriesDPreferredStockAmount	0	usd
CY2021	rcrt	Reclassification Of Warrant Derivative To Liabilities Related To Series D Unit Sales1 ReclassificationOfWarrantDerivativeToLiabilitiesRelatedToSeriesDUnitSales1	10182476	usd
CY2021	rcrt	Issuance Of Common Shares And Pre Funded Warrants Upon Conversion Of Series D Preferred Stock Amount IssuanceOfCommonSharesAndPreFundedWarrantsUponConversionOfSeriesDPreferredStockAmount	0	usd
CY2021	rcrt	Issuance Of Common Shares Upon Conversion Of Series F Preferred Stock Amount IssuanceOfCommonSharesUponConversionOfSeriesFPreferredStockAmount	0	usd
CY2021	rcrt	Issuance Of Shares For One Wire Acquisition Amount IssuanceOfSharesForOneWireAcquisitionAmount	1436777	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	519239	usd
CY2021	rcrt	Issuance Of Common Shares For Accounts Payable Amount IssuanceOfCommonSharesForAccountsPayableAmount	140000	usd
CY2021	rcrt	Proceeds From Sale Of Common Stock And Warrants In Offering Amount ProceedsFromSaleOfCommonStockAndWarrantsInOfferingAmount	12003600	usd
CY2021	rcrt	Offering Costs OfferingCosts	-1651889	usd
CY2021	rcrt	Cost Related To Modification Of Warrants CostRelatedToModificationOfWarrants	12624	usd
CY2021	rcrt	Deferred Offering Costs Amount DeferredOfferingCostsAmount	-78038	usd
CY2021	rcrt	Common Stock Issued For The Exercises Of Warrants Shares Amount CommonStockIssuedForTheExercisesOfWarrantsSharesAmount	0	usd
CY2021	rcrt	Issuance Of Common Shares Upon Conversion Of Series E Preferred Stock Amount IssuanceOfCommonSharesUponConversionOfSeriesEPreferredStockAmount	0	usd
CY2021	rcrt	Issuance Of Common Shares For Parrut Acquisition Amount IssuanceOfCommonSharesForParrutAcquisitionAmount	1264551	usd
CY2021	rcrt	Issuance Of Common Shares For Novo Acquisition Amount IssuanceOfCommonSharesForNovoAcquisitionAmount	2019583	usd
CY2021	rcrt	Proceeds From Sale Of Common Stock Related To Over Allotment Offering Amount ProceedsFromSaleOfCommonStockRelatedToOverAllotmentOfferingAmount	1796400	usd
CY2021	us-gaap	Payments For Previous Acquisition PaymentsForPreviousAcquisition	1125000	usd
CY2021	rcrt	Rs Us Issued For Services Amount RSUsIssuedForServicesAmount	0	usd
CY2021	rcrt	Fractional Shares Issued From Stock Split Amount FractionalSharesIssuedFromStockSplitAmount	0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16334615	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16090225	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16090225	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3053180	usd
CY2022	rcrt	Stock Based Compensation Rs Us StockBasedCompensationRSUs	815478	usd
CY2022	rcrt	Common Stock Issued For The Exercises Of Warrants Shares Amount CommonStockIssuedForTheExercisesOfWarrantsSharesAmount	152244	usd
CY2022	rcrt	Common Stock Issued For Restricted Stock Units Amount CommonStockIssuedForRestrictedStockUnitsAmount	0	usd
CY2022	rcrt	Issuance Of Warrants To Purchase To Common Stock IssuanceOfWarrantsToPurchaseToCommonStock	1032842	usd
CY2022	rcrt	Anti Dilution Adjustment To Warrants AntiDilutionAdjustmentToWarrants	0	usd
CY2022	rcrt	Issuance Of Earn Out Shares Amount IssuanceOfEarnOutSharesAmount	0	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	409036	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-16474688	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5078317	usd
CY2022	us-gaap	Profit Loss ProfitLoss	16474688	usd
CY2021	us-gaap	Profit Loss ProfitLoss	16334615	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3663953	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2742162	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	492906	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	927847	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1205195	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	24925	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4106040	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5400975	usd
CY2022	rcrt	Recognized Loss Gain On Marketable Securities RecognizedLossGainOnMarketableSecurities	0	usd
CY2021	rcrt	Recognized Loss Gain On Marketable Securities RecognizedLossGainOnMarketableSecurities	-1424	usd
CY2022	rcrt	Loans Principal Paid Directly Through Grant LoansPrincipalPaidDirectlyThroughGrant	0	usd
CY2021	rcrt	Loans Principal Paid Directly Through Grant LoansPrincipalPaidDirectlyThroughGrant	2992	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	499031	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2503160	usd
CY2022	rcrt	Warrant Modification Expense WarrantModificationExpense	152244	usd
CY2021	rcrt	Warrant Modification Expense WarrantModificationExpense	12624	usd
CY2022	rcrt	Initial Derivative Expense InitialDerivativeExpense	0	usd
CY2021	rcrt	Initial Derivative Expense InitialDerivativeExpense	3585983	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	4420539	usd
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	2530325	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	7315580	usd
CY2022	rcrt	Factoring Discount Fee And Interest FactoringDiscountFeeAndInterest	-179303	usd
CY2021	rcrt	Factoring Discount Fee And Interest FactoringDiscountFeeAndInterest	0	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	250000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	0	usd
CY2022	rcrt	Change In Fair Value Of Earn Out Liability ChangeInFairValueOfEarnOutLiability	26604	usd
CY2021	rcrt	Change In Fair Value Of Earn Out Liability ChangeInFairValueOfEarnOutLiability	35294	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1492093	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4690668	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-49033	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	7909	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-253149	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	74742	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-594967	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1991446	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-163672	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	-746756	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	79244	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	77304	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2840	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-531231	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	525767	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6948288	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9015644	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1325491	usd
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2238958	usd
CY2022	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	1050000	usd
CY2021	us-gaap	Proceeds From Sale Of Intangible Assets ProceedsFromSaleOfIntangibleAssets	0	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74606	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-350097	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2238958	usd
CY2022	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	4077127	usd
CY2021	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	250000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2153200	usd
CY2022	rcrt	Deferred Offering Cost DeferredOfferingCost	0	usd
CY2021	rcrt	Deferred Offering Cost DeferredOfferingCost	78038	usd
CY2022	us-gaap	Repayments Of Longterm Loans From Vendors RepaymentsOfLongtermLoansFromVendors	2013661	usd
CY2021	us-gaap	Repayments Of Longterm Loans From Vendors RepaymentsOfLongtermLoansFromVendors	723611	usd
CY2022	rcrt	Repayments Of Sale Of Future Revenues RepaymentsOfSaleOfFutureRevenues	0	usd
CY2021	rcrt	Repayments Of Sale Of Future Revenues RepaymentsOfSaleOfFutureRevenues	10904	usd
CY2022	rcrt	Proceeds From Factoring Agreement ProceedsFromFactoringAgreement	7303537	usd
CY2021	rcrt	Proceeds From Factoring Agreement ProceedsFromFactoringAgreement	0	usd
CY2022	rcrt	Repayments Of Factoring Agreement RepaymentsOfFactoringAgreement	3705876	usd
CY2021	rcrt	Repayments Of Factoring Agreement RepaymentsOfFactoringAgreement	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13800000	usd
CY2022	rcrt	Offering Cost OfferingCost	0	usd
CY2021	rcrt	Offering Cost OfferingCost	-1651889	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5661127	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13738758	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1637258	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2484156	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2584062	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99906	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	946804	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2584062	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	256648	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	240980	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	rcrt	Accounts Receivable Owed Under Factoring Agreement Collected Directly By Factor AccountsReceivableOwedUnderFactoringAgreementCollectedDirectlyByFactor	3495683	usd
CY2021	rcrt	Accounts Receivable Owed Under Factoring Agreement Collected Directly By Factor AccountsReceivableOwedUnderFactoringAgreementCollectedDirectlyByFactor	0	usd
CY2022	rcrt	Purchase Price Measurement Period Adjustment To Goodwill And Accounts Receivable PurchasePriceMeasurementPeriodAdjustmentToGoodwillAndAccountsReceivable	35644	usd
CY2021	rcrt	Purchase Price Measurement Period Adjustment To Goodwill And Accounts Receivable PurchasePriceMeasurementPeriodAdjustmentToGoodwillAndAccountsReceivable	0	usd
CY2022	rcrt	Common Shares Issued To Settle Accrued Liability Non Cash CommonSharesIssuedToSettleAccruedLiabilityNonCash	409036	usd
CY2021	rcrt	Common Shares Issued To Settle Accrued Liability Non Cash CommonSharesIssuedToSettleAccruedLiabilityNonCash	0	usd
CY2022	rcrt	Original Issue Discount Deducted From Convertible Note Proceeds OriginalIssueDiscountDeductedFromConvertibleNoteProceeds	0	usd
CY2021	rcrt	Original Issue Discount Deducted From Convertible Note Proceeds OriginalIssueDiscountDeductedFromConvertibleNoteProceeds	342554	usd
CY2022	rcrt	Debt Discount On Warrants Granted With Notes DebtDiscountOnWarrantsGrantedWithNotes	1632842	usd
CY2021	rcrt	Debt Discount On Warrants Granted With Notes DebtDiscountOnWarrantsGrantedWithNotes	0	usd
CY2022	rcrt	Debt Costs Deducted From Convertible Note Proceeds DebtCostsDeductedFromConvertibleNoteProceeds	0	usd
CY2021	rcrt	Debt Costs Deducted From Convertible Note Proceeds DebtCostsDeductedFromConvertibleNoteProceeds	334800	usd
CY2022	rcrt	Notes And Accrued Interest Converted To Common Stock NotesAndAccruedInterestConvertedToCommonStock	0	usd
CY2021	rcrt	Notes And Accrued Interest Converted To Common Stock NotesAndAccruedInterestConvertedToCommonStock	4557718	usd
CY2022	rcrt	Notes Payable And Accrued Interest Exchanged For Debentures NotesPayableAndAccruedInterestExchangedForDebentures	0	usd
CY2021	rcrt	Notes Payable And Accrued Interest Exchanged For Debentures NotesPayableAndAccruedInterestExchangedForDebentures	252430	usd
CY2022	rcrt	Accounts Payable Paid With Common Stock AccountsPayablePaidWithCommonStock	0	usd
CY2021	rcrt	Accounts Payable Paid With Common Stock AccountsPayablePaidWithCommonStock	140000	usd
CY2022	rcrt	Accrued Compensation Paid With Common Stock AccruedCompensationPaidWithCommonStock	0	usd
CY2021	rcrt	Accrued Compensation Paid With Common Stock AccruedCompensationPaidWithCommonStock	16425	usd
CY2022	rcrt	Warrant Derivative Liability Extinguished WarrantDerivativeLiabilityExtinguished	0	usd
CY2021	rcrt	Warrant Derivative Liability Extinguished WarrantDerivativeLiabilityExtinguished	10182476	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	103953	usd
CY2022	rcrt	Deferred Offering Costs Charged To Additional Paid In Capital DeferredOfferingCostsChargedToAdditionalPaidInCapital	0	usd
CY2021	rcrt	Deferred Offering Costs Charged To Additional Paid In Capital DeferredOfferingCostsChargedToAdditionalPaidInCapital	78038	usd
CY2022	rcrt	Common Stock Issued To Be Issued For Asset Acquisitions CommonStockIssuedToBeIssuedForAssetAcquisitions	0	usd
CY2021	rcrt	Common Stock Issued To Be Issued For Asset Acquisitions CommonStockIssuedToBeIssuedForAssetAcquisitions	11340284	usd
CY2022	rcrt	Earn Out Liability Consideration For Acquisition EarnOutLiabilityConsiderationForAcquisition	0	usd
CY2021	rcrt	Earn Out Liability Consideration For Acquisition EarnOutLiabilityConsiderationForAcquisition	543297	usd
CY2022	rcrt	Loans Issued As Consideration For Acquisitions LoansIssuedAsConsiderationForAcquisitions	0	usd
CY2021	rcrt	Loans Issued As Consideration For Acquisitions LoansIssuedAsConsiderationForAcquisitions	4750000	usd
CY2022	rcrt	Shares Issued For Upsider Earn Out Liability SharesIssuedForUpsiderEarnOutLiability	0	usd
CY2021	rcrt	Shares Issued For Upsider Earn Out Liability SharesIssuedForUpsiderEarnOutLiability	1394768	usd
CY2022	rcrt	Warrant Derivative Liability At Inception Recorded As Debt Discount WarrantDerivativeLiabilityAtInceptionRecordedAsDebtDiscount	0	usd
CY2021	rcrt	Warrant Derivative Liability At Inception Recorded As Debt Discount WarrantDerivativeLiabilityAtInceptionRecordedAsDebtDiscount	2374076	usd
CY2022	rcrt	Prepayment Of Shares Issued For Services PrepaymentOfSharesIssuedForServices	0	usd
CY2021	rcrt	Prepayment Of Shares Issued For Services PrepaymentOfSharesIssuedForServices	237382	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	3838425	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	934219	usd
CY2021	rcrt	Bad Debt Expense BadDebtExpense	927847	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results and outcomes may differ from management’s estimates and assumptions. Included in these estimates are assumptions used to estimate collection of accounts receivable, fair value of marketable securities, fair value of assets acquired and liabilities assumed in asset acquisitions and the estimated useful life of assets acquired, fair value of contingent consideration in asset acquisitions and business combinations, fair value of derivative liabilities, fair value of securities issued for acquisitions and business combinations, fair value of assets acquired and liabilities assumed in business combinations, fair value of intangible assets and goodwill, fair value of capitalized software, fair value of non-monetary transactions, deferred income tax asset valuation allowances, and valuation of stock based compensation expense.</p>
CY2021Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	1667798	usd
CY2021Q4	rcrt	Deferred Revenues DeferredRevenues	746449	usd
CY2022	rcrt	Deferred Revenue Addition DeferredRevenueAddition	215219	usd
CY2021	rcrt	International Sources Revenue InternationalSourcesRevenue	0.023	pure
CY2021	rcrt	Depreciation Expense DepreciationExpense	1154	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of December 31, 2022, one customer accounted for more than 10% of the accounts receivable balance, at 28%. As of December 31, 2021, two customers accounted for more than 10% of the accounts receivable balance, at 14% and 12%, for a total of 26%.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the year ended December 31, 2022 one customer accounted for 10% or more of total revenue, at 14%. For the year ended December 31, 2021 one customer accounted for 10% or more of total revenue, at 12%.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We use a related party firm located overseas for software development and maintenance related to our website and the platform underlying our operations. One of our employees and principal shareholders is an employee of this firm but exerts control over this firm (see Note 12). </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We were a party to a license agreement with a related party firm (see Note 12). Pursuant to the license agreement the firm has granted us an exclusive license to use certain candidate matching software and render certain related services to us. If this relationship was terminated or if the firm was to cease doing business or cease to support the applications we currently utilize, we may be forced to expend significant time and resources to replace the licensed software. Further, the necessary replacements may not be available on a timely basis on favorable terms, or at all. If we were to lose the ability to use this software our business and operating results could be materially and adversely affected.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We had used a related party firm to provide certain employer of record services (see Note 12).</p>
CY2021	rcrt	Advertising And Marketing Costs AdvertisingAndMarketingCosts	472213	usd
CY2022Q4	rcrt	Earnout Liability EarnoutLiability	0	usd
CY2021Q4	rcrt	Earnout Liability EarnoutLiability	578591	usd
CY2021Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	578591	usd
CY2022	rcrt	Balance At Beginning Of Period Of Derivative Liability BalanceAtBeginningOfPeriodOfDerivativeLiability	0	usd
CY2021	rcrt	Balance At Beginning Of Period Of Derivative Liability BalanceAtBeginningOfPeriodOfDerivativeLiability	11537997	usd
CY2022	rcrt	Additionsto Derivative Instruments AdditionstoDerivativeInstruments	0	usd
CY2021	rcrt	Additionsto Derivative Instruments AdditionstoDerivativeInstruments	5960059	usd
CY2022	rcrt	Reclassification To Equity Upon Modification Or Cancellation Of Warrants ReclassificationToEquityUponModificationOrCancellationOfWarrants	0	usd
CY2021	rcrt	Reclassification To Equity Upon Modification Or Cancellation Of Warrants ReclassificationToEquityUponModificationOrCancellationOfWarrants	-10182476	usd
CY2022	rcrt	Gain Loss On Change In Fair Value Of Derivative Liability GainLossOnChangeInFairValueOfDerivativeLiability	0	usd
CY2021	rcrt	Gain Loss On Change In Fair Value Of Derivative Liability GainLossOnChangeInFairValueOfDerivativeLiability	-7315580	usd
CY2022	rcrt	Balance At End Of Period Derivativeliability BalanceAtEndOfPeriodDerivativeliability	0	usd
CY2021	rcrt	Balance At End Of Period Derivativeliability BalanceAtEndOfPeriodDerivativeliability	0	usd
CY2020Q4	rcrt	Balance At Beginningliability Measured At Fair Value BalanceAtBeginningliabilityMeasuredAtFairValue	0	usd
CY2021	rcrt	Novo Group Acquisition Acquisitions And Settlements NovoGroupAcquisitionAcquisitionsAndSettlements	543297	usd
CY2021	rcrt	Change In Fair Value Of Earn Out Liability1 ChangeInFairValueOfEarnOutLiability1	-35294	usd
CY2021Q4	rcrt	Balance At Beginningliability Measured At Fair Value83 BalanceAtBeginningliabilityMeasuredAtFairValue83	578591	usd
CY2022	rcrt	Gain Loss On Debt Extinguishment GainLossOnDebtExtinguishment	-605195	usd
CY2021Q4	rcrt	Fair Value Of Contingent Consideration Liabilities FairValueOfContingentConsiderationLiabilities	578591	usd
CY2021	rcrt	Valuation Technique ValuationTechnique	Discounted cash flow
CY2021	rcrt	Significant Unobservable Input SignificantUnobservableInput	Projected revenue and probability of achievement
CY2022	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity. This ASU removes certain separation models in ASC 470-20 for convertible instruments, and, as a result, embedded conversion features that do not require bifurcation under ASC 815 are no longer subject to separation into an equity classified component. Consequently, a convertible debt instrument, shall be accounted for as a single liability measured at its amortized cost. The Company adopted ASU 2020-06 on January 1, 2021 using the modified retrospective transition method.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s derivative financial instruments consisted of derivatives related to the warrants issued with the sale of our convertible notes in 2020 and 2021 (see Note 8) and the warrants issued with the sale of our Series D Preferred Stock in 2020 and 2019 (see Notes 9 and 10). The accounting treatment of derivative financial instruments requires that we record the derivatives at their fair values as of the inception date of the debt agreements and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense at each balance sheet date. If the fair value of the derivatives was higher at the subsequent balance sheet date, we recorded a non-operating, non-cash charge. If the fair value of the derivatives was lower at the subsequent balance sheet date, we recorded non-operating, non-cash income. Upon the determination that an instrument is no longer subject to derivative accounting, the fair value of the derivative instrument at the date of such determination will be reclassified to paid-in capital. The entirety of our derivative financial instruments was eliminated in July 2021 upon conversion of certain outstanding warrants to common stock and agreement by investors to modify certain warrants to eliminate the feature creating the derivative liability in the remaining outstanding warrants (see Note 10). </p>
CY2022	rcrt	Deemed Dividend DeemedDividend	-1921213	usd
CY2021	rcrt	Antidilutive Securities AntidilutiveSecurities	10012635	shares
CY2022	rcrt	Net Income Loss1 NetIncomeLoss1	-16474688	usd
CY2021	rcrt	Net Income Loss1 NetIncomeLoss1	-16334615	usd
CY2022	rcrt	Deemed Dividend DeemedDividend	-1921213	usd
CY2021	rcrt	Deemed Dividend DeemedDividend	0	usd
CY2022	rcrt	Net Income Loss Numerator Basic Computation NetIncomeLossNumeratorBasicComputation	-18395901	usd
CY2021	rcrt	Net Income Loss Numerator Basic Computation NetIncomeLossNumeratorBasicComputation	-16334615	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	40860	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	175263	usd
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	200000	usd
CY2021Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	0	usd
CY2022Q4	rcrt	Prepaid Shares Issued For Services PrepaidSharesIssuedForServices	0	usd
CY2021Q4	rcrt	Prepaid Shares Issued For Services PrepaidSharesIssuedForServices	237382	usd
CY2022Q4	rcrt	Employee Advance Current EmployeeAdvanceCurrent	8500	usd
CY2021Q4	rcrt	Employee Advance Current EmployeeAdvanceCurrent	0	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3302	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	111040	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	2886	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	22394	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	255548	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	546079	usd
CY2022Q4	rcrt	Available For Sale Securities And Held To Maturity Security AvailableForSaleSecuritiesAndHeldToMaturitySecurity	42720	usd
CY2021	rcrt	Available For Sale Equity Securities Gross Unrealized Losses AvailableForSaleEquitySecuritiesGrossUnrealizedLosses	42720	usd
CY2022Q4	rcrt	Shares Owned In Marketable Securities SharesOwnedInMarketableSecurities	0	shares
CY2021Q4	rcrt	Shares Owned In Marketable Securities SharesOwnedInMarketableSecurities	178000	shares
CY2022Q4	rcrt	Average Per Share Market Price AveragePerShareMarketPrice	0
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1424	usd
CY2022	rcrt	Total Marketable Securities Gain Loss TotalMarketableSecuritiesGainLoss	0	usd
CY2021	rcrt	Total Marketable Securities Gain Loss TotalMarketableSecuritiesGainLoss	-1424	usd
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2021Q4	rcrt	Available For Sale Security Noncurrent AvailableForSaleSecurityNoncurrent	0	usd
CY2020Q4	rcrt	Available For Sale Security Noncurrent AvailableForSaleSecurityNoncurrent	1424	usd
CY2022	rcrt	Payments To Acquire Available For Sale Security PaymentsToAcquireAvailableForSaleSecurity	0	usd
CY2021	rcrt	Payments To Acquire Available For Sale Security PaymentsToAcquireAvailableForSaleSecurity	0	usd
CY2022	rcrt	Proceeds On Sales Of Securities ProceedsOnSalesOfSecurities	0	usd
CY2021	rcrt	Proceeds On Sales Of Securities ProceedsOnSalesOfSecurities	0	usd
CY2022	rcrt	Recognized Losses RecognizedLosses	0	usd
CY2021	rcrt	Recognized Losses RecognizedLosses	-1424	usd
CY2022Q4	rcrt	Available For Sale Security Noncurrent AvailableForSaleSecurityNoncurrent	0	usd
CY2021Q4	rcrt	Available For Sale Security Noncurrent AvailableForSaleSecurityNoncurrent	0	usd
CY2021Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	6731852	usd
CY2020Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	3517315	usd
CY2021	rcrt	Impairment Expense ImpairmentExpense	2530325	usd
CY2022	rcrt	Impairment Expense ImpairmentExpense	582114	usd
CY2021Q4	us-gaap	Goodwill Goodwill	7718842	usd
CY2020Q4	us-gaap	Goodwill Goodwill	3517315	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	6731852	usd
CY2022	rcrt	Goodwill Other GoodwillOther	7718842	usd
CY2021	rcrt	Goodwill Other GoodwillOther	10249167	usd
CY2022	rcrt	Purchase Price Measurement Period Adjustment PurchasePriceMeasurementPeriodAdjustment	35644	usd
CY2021	rcrt	Purchase Price Measurement Period Adjustment PurchasePriceMeasurementPeriodAdjustment	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	582114	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2530325	usd
CY2022Q4	rcrt	Goodwill1 Goodwill1	7101084	usd
CY2021Q4	rcrt	Goodwill1 Goodwill1	7718842	usd
CY2019Q1	rcrt	Future Amortization Of Intangible Assets Remainder Of Year FutureAmortizationOfIntangibleAssetsRemainderOfYear	1910072	usd
CY2022	us-gaap	Officers Compensation OfficersCompensation	50000	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	125000	usd
CY2021	rcrt	Bonus Per Month BonusPerMonth	11600000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13972539	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13647048	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-7555422	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3905216	usd
CY2022Q4	rcrt	Total Total	6417117	usd
CY2021Q4	rcrt	Total Total	9741832	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2578692	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9741832	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3650206	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2741008	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	1237047	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	739547	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	455683	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	121279	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	2738	usd
CY2022Q4	rcrt	Finite Lived Intangible Assets Amortization Expense Rolling After Yearour FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearour	22398	usd
CY2022	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	3838425	usd
CY2022	us-gaap	Cooperative Advertising Expense CooperativeAdvertisingExpense	50000	usd
CY2021	us-gaap	Cooperative Advertising Expense CooperativeAdvertisingExpense	200000	usd
CY2022Q4	rcrt	Gain On Sale Of Intangible Asset GainOnSaleOfIntangibleAsset	250000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1000000	usd
CY2022Q4	rcrt	Gain On Sale Of Intangible Asset GainOnSaleOfIntangibleAsset	1000000	usd
CY2022	rcrt	Repayments Paid RepaymentsPaid	567001	usd
CY2022	rcrt	Initial Discount InitialDiscount	142491	usd
CY2022	rcrt	Amortized Discount To Interest Expense AmortizedDiscountToInterestExpense	0	usd
CY2021	rcrt	Amortized Discount To Interest Expense AmortizedDiscountToInterestExpense	2719	usd
CY2022	rcrt	Unamortized Discount To Interest Expense UnamortizedDiscountToInterestExpense	0	usd
CY2022	rcrt	Unamortized Discount Outstanding Amount UnamortizedDiscountOutstandingAmount	0	usd
CY2022	us-gaap	Manufacturing Costs ManufacturingCosts	179303	usd
CY2022Q4	rcrt	Term Loan TermLoan	0	usd
CY2021Q4	rcrt	Term Loan TermLoan	50431	usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	6153272	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	4299831	usd
CY2022Q4	rcrt	Factoring Arrangemen FactoringArrangemen	281277	usd
CY2021Q4	rcrt	Factoring Arrangemen FactoringArrangemen	0	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	6434549	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	4350262	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	-1473351	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	0	usd
CY2022Q4	rcrt	Less Current Portions LessCurrentPortions	-3700855	usd
CY2021Q4	rcrt	Less Current Portions LessCurrentPortions	-1712387	usd
CY2022Q4	rcrt	Notes And Loans Payable1 NotesAndLoansPayable1	1260343	usd
CY2021Q4	rcrt	Notes And Loans Payable1 NotesAndLoansPayable1	2637875	usd
CY2022Q4	rcrt	Strike Price Per Share Maximum StrikePricePerShareMaximum	2.00
CY2022Q4	rcrt	Strike Price Per Share Minimum StrikePricePerShareMinimum	0.98
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.00342554
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	21375	shares
CY2021Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	8000	shares
CY2021Q1	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	6479	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	31250000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	rcrt	Common Stock Shares Outstanding1 CommonStockSharesOutstanding1	16277764	shares
CY2022	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-2.5
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q3	rcrt	Stock Unit Issue StockUnitIssue	360000	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.00
CY2022	rcrt	Proceed From Underwritten Public Offering Amount ProceedFromUnderwrittenPublicOfferingAmount	13800000	usd
CY2022	rcrt	Total Restricted Stock Units Expense TotalRestrictedStockUnitsExpense	1052865	usd
CY2021	rcrt	Total Restricted Stock Units Expense TotalRestrictedStockUnitsExpense	825951	usd
CY2022	rcrt	Schedule Ofrestricted Stock Grant Activitytabletextblock ScheduleOfrestrictedStockGrantActivitytabletextblock	<table cellpadding="0" style="border-spacing:0;font-size:10pt;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stock Awards</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Outstanding at December 31, 2020</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">221,600</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">158,790</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">(151,290 </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested and issuable</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">(83,100 </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited or cancelled</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Outstanding at December 31, 2021</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">146,000</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Granted</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">95,825</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested and issued</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">(88,325 </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Vested and issuable</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">(7,500 </p></td><td style="width:1%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">)</p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Forfeited or cancelled</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">-</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Outstanding at December 31, 2022</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">146,000</p></td><td style="width:1%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	89172	shares
CY2021	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	354387	shares
CY2021	rcrt	Debt Instrument Accrued Interest DebtInstrumentAccruedInterest	2302	usd
CY2021Q3	rcrt	Debt Instrument Accrued Interest DebtInstrumentAccruedInterest	115593	usd
CY2021Q3	rcrt	Penalty Amount PenaltyAmount	253767	usd
CY2021Q3	rcrt	Unamortized Discount UnamortizedDiscount	1666314	usd
CY2021Q3	rcrt	Additional Paid In Capitals AdditionalPaidInCapitals	4291102	usd
CY2021Q4	rcrt	Stock Unit Issue StockUnitIssue	224163	shares
CY2021Q1	rcrt	Stock Unit Issue StockUnitIssue	271153	shares
CY2021Q2	rcrt	Stock Unit Issue StockUnitIssue	155327	shares
CY2021Q3	rcrt	Stock Unit Issue StockUnitIssue	257545	shares
CY2021Q3	rcrt	Stock Unit Issue StockUnitIssue	508711	shares
CY2022Q4	rcrt	Stock Unit Issue StockUnitIssue	321390	shares
CY2021Q4	rcrt	Stock Unit Issued StockUnitIssued	190000	shares
CY2020Q2	rcrt	Stock Unit Issued StockUnitIssued	1108000	shares
CY2017Q4	rcrt	Stock Unit Issued StockUnitIssued	2700000	shares
CY2022Q4	rcrt	Stock Unit Issued StockUnitIssued	3427946	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.10	pure
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	1.10	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	20000	shares
CY2021Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	6.75
CY2021Q1	rcrt	Sharebased Compensation Arrangement By Sharebased Payment Award At The Time Of Grant SharebasedCompensationArrangementBySharebasedPaymentAwardAtTheTimeOfGrant	134986	usd
CY2021Q1	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.54	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	159000	shares
CY2021Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	8.625
CY2021Q1	rcrt	Sharebased Compensation Arrangement By Sharebased Payment Award At The Time Of Grant SharebasedCompensationArrangementBySharebasedPaymentAwardAtTheTimeOfGrant	1371231	usd
CY2021Q1	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.46	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	20000	shares
CY2021Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	8.125
CY2021Q1	rcrt	Sharebased Compensation Arrangement By Sharebased Payment Award At The Time Of Grant SharebasedCompensationArrangementBySharebasedPaymentAwardAtTheTimeOfGrant	162491	usd
CY2021Q1	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.59	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0083	pure
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	11800	shares
CY2021Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	8.125
CY2021Q2	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	95925	usd
CY2021Q2	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.50	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	12000	shares
CY2021Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	8.125
CY2021Q2	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	97551	usd
CY2021Q2	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.50	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	16600	shares
CY2021Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	8.125
CY2021Q2	rcrt	Compensation Expense Over Vesting Period CompensationExpenseOverVestingPeriod	134946	usd
CY2021Q2	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.50	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	8800	shares
CY2021Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	8.125
CY2021Q2	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	3.50	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.008	pure
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	29000	shares
CY2021Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.50
CY2021Q2	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Dividend Yeild ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateDividendYeild	0	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.35	pure
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0007	pure
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	110000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.96
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over two years, with the first portion vesting on October 8, 2021
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	25050	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.96
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	35000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.05
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vested 50% after 60 days and 50% after 180 days, with the first portion having vested on October 31, 2021
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	10000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.05
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over two years, with the first portion vesting on November 30, 2021
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	25000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.05
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with a one year cliff, with the first portion vesting on August 31, 2022
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	300000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.65
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vested 25% at grant date on September 1, 2021 and 75% on March 1, 2023
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	100000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.65
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options were vested at grant date on September 6, 2022
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	7500	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.96
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over two years, with the first portion vesting on December10, 2021
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	349000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.96
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over two years, with a one year cliff, with the first portion vesting on September 10, 2022
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	274500	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.96
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on December 10, 2021
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	200000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.59
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over two years, with a one year cliff, with the first portion vesting on September 10, 2022
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	50000	shares
CY2021Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.97
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on December 13, 2021
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	90000	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.45
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with a one year cliff, with the first portion vesting on October 3, 2022
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	43900	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.45
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on January 3, 2022.
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	100000	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.45
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest monthly over two years, with an eighth of the options vesting immediately.
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	72500	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.96
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with a one year cliff, with the first portion vesting on October 28, 2022.
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	7500	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.31
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on February 23, 2022.
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	242850	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.86
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with a one year cliff, with the first portion vesting on October 28, 2022.
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	35000	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.60
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vested 50% at January 2, 2022 and 50% on February 2, 2022.
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	7500	shares
CY2021Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	3.96
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on March 10, 2022.
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	20000	shares
CY2022Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.64
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vested 50% on March 3, 2022 and 50% on April 3, 2022
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	15000	shares
CY2022Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.40
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vest quarterly over a four-year period
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	15000	shares
CY2022Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.40
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vest quarterly over a four-year period
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	60000	shares
CY2022Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.40
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vest quarterly over a four-year period
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	52500	shares
CY2022Q1	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.87
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on June 11, 2022
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	25000	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.47
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on July 1, 2022
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	25000	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.12
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on July 4, 2022
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	37000	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.12
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on July 1, 2022
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	57500	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.12
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on July 5, 2022
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	120100	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	2.03
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years, with the first portion vesting on July 7, 2022
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	35000	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.60
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest monthly over two months, with the first portion vesting on May 28, 2022
CY2022Q4	rcrt	Non Vested Stock Options Periods Five Year NonVestedStockOptionsPeriodsFiveYear	43124	usd
CY2022Q4	rcrt	Intrinsic Value Of Options Outstanding IntrinsicValueOfOptionsOutstanding	0	usd
CY2022Q4	rcrt	Intrinsic Value Of Options Exercisable IntrinsicValueOfOptionsExercisable	0	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	5000	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.07
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vested immediately
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	22500	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.07
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years with a one-year cliff, with the first portion vesting on May 17, 2023
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	25461	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.00
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest monthly over one year, with the first portion vesting on July 6, 2022
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	37500	shares
CY2022Q2	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.00
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years with a one-year cliff, with the first portion vesting on June 27, 2023
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	270000	shares
CY2022Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.31
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options vest immediately
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	550000	shares
CY2022Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.31
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest months over two years
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	80000	shares
CY2022Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.10
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest months over two years
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	190000	shares
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.47
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest quarterly over four years
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	25000	shares
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	0.37
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights	The options will vest monthly over one year
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2022	rcrt	Stock Based Compensation Expenses StockBasedCompensationExpenses	3041815	usd
CY2021	rcrt	Stock Based Compensation Expenses StockBasedCompensationExpenses	4257434	usd
CY2022	rcrt	Unrecognized Compensation Cost UnrecognizedCompensationCost	2527736	usd
CY2022Q4	rcrt	Non Vested Stock Options Periods Two Year NonVestedStockOptionsPeriodsTwoYear	1366691	usd
CY2022Q4	rcrt	Non Vested Stock Options Periods Three Year NonVestedStockOptionsPeriodsThreeYear	715711	usd
CY2022Q4	rcrt	Non Vested Stock Options Periods Four Year NonVestedStockOptionsPeriodsFourYear	402210	usd
CY2022Q3	rcrt	Description Of Warrants DescriptionOfWarrants	The exercise price was reduced to $2.00 from $5.00 and the number of warrants was increased from 1,512,090 to 2,447,045. We have recorded a deemed dividend for the change in value due to the anti-dilution adjustments and an increase to the carrying value of the warrants of $658,266 as a result of the trigger of the anti-dilution provisions.
CY2021Q3	rcrt	Description Of Warrants DescriptionOfWarrants	from 1,510,417 to 3,020,834 and reduced the exercise price from $2.00 to $0.98 due to anti-dilution provisions in these warrants
CY2022Q4	rcrt	Warrants For Service Issued Shares WarrantsForServiceIssuedShares	30000	shares
CY2022Q4	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	1.00
CY2022	rcrt	Placement Agent Warrants Description PlacementAgentWarrantsDescription	On January 5, 2021 and January 20, 2021, the Company issued 28,125 and 111,825 three year term common stock warrants respectively for a total of 139,950 warrants with an exercise price of $5.00. On July 2, 2021, the 139,950 warrants were reduced to 36,364 with an exercise price of $6.25. See "Convertible Debenture Warrants and Placement Agent Warrants” below
CY2021Q1	rcrt	Note Holder Warrants Description NoteHolderWarrantsDescription	On January 5, 2021, January 20, 2021 and February 3, 2021, the Company issued 140,625, 559,125, and 70,996 three year term common stock warrants respectively for a total of 770,746 warrants with an exercise price of $5.00. On July 2, 2021, the 770,746 warrants were increased to 772,303 with an exercise price of $5.00. See "Convertible Debenture Warrants and Placement Agent Warrants” below.
CY2021Q3	rcrt	Stock Unit Issued StockUnitIssued	2400000	shares
CY2021Q3	rcrt	Stock Unit Price Per Share StockUnitPricePerShare	5.00
CY2022	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	5.50
CY2022Q4	rcrt	Underwriter Warrants UnderwriterWarrants	360000	shares
CY2021Q3	rcrt	Stock Unit Issued StockUnitIssued	360000	shares
CY2021	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.99
CY2021Q3	rcrt	Representative Warrants RepresentativeWarrants	240000	shares
CY2021Q3	rcrt	Representative Warrants Price Per Share RepresentativeWarrantsPricePerShare	6.25
CY2021Q3	rcrt	Warrants Upon Conversion Of Convertible Debentures Description WarrantsUponConversionOfConvertibleDebenturesDescription	On July 2, 2021, the Company issued 1,489,596 common stock warrants with an exercise price of $5.50 in conjunction with the conversion of all $5,588,359 of convertible debentures outstanding, $115,593 of accrued interest through July 2, 2021 and a penalty amount of $253,767 on the convertible debentures issued in May/September 2020 (as discussed previously in Note 9 under Common Stock)
CY2021Q2	rcrt	Warrants For Service Issued Shares WarrantsForServiceIssuedShares	20000	shares
CY2021Q2	rcrt	Warrants For Service Exercise Price WarrantsForServiceExercisePrice	5.00
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	211614	usd
CY2022	us-gaap	Other Income OtherIncome	1886212	usd
CY2022	rcrt	Series D Warrants Exchanged Shares SeriesDWarrantsExchangedShares	522108	shares
CY2022Q4	rcrt	Derivative Liability DerivativeLiability	2404182	usd
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	6874533	usd
CY2022	rcrt	Initial Derivative Expense Charged To Interest InitialDerivativeExpenseChargedToInterest	3585983	usd
CY2022	rcrt	Other Expense Related To The Change In The Fair Value Of The Derivative OtherExpenseRelatedToTheChangeInTheFairValueOfTheDerivative	676177	usd
CY2022	rcrt	Other Income Related To The Change In The Fair Value Of The Derivative OtherIncomeRelatedToTheChangeInTheFairValueOfTheDerivative	5429368	usd
CY2022Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	7405224	usd
CY2021	rcrt	Number Of Placement Agent Warrants Issued Reduced NumberOfPlacementAgentWarrantsIssuedReduced	287606	shares
CY2022	rcrt	Number Of Placement Agent Warrants Issued Reduced NumberOfPlacementAgentWarrantsIssuedReduced	72728	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1461378	shares
CY2020Q4	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding Weighted Average Exercise Price Beginning Balance ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceBeginningBalance	4.60
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	6008237	shares
CY2021	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsGrantsInPeriodWeightedAverageExercisePrice	4.46
CY2021	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instrument Warrants Outstanding Cancelled Pursuant To Modification ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentWarrantsOutstandingCancelledPursuantToModification	265148	shares
CY2021	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Weighted Average Price Per Share Cancelled Pursuant To Modification ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsWeightedAveragePricePerShareCancelledPursuantToModification	1.92
CY2022	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Anti Dilution Previsions ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsAntiDilutionPrevisions	0.98
CY2021	rcrt	Sharebasedcompensationarrangementbysharebasedpaymentawardwarrantsweightedaveragepricepersharereissued Pursuant To Modification SharebasedcompensationarrangementbysharebasedpaymentawardwarrantsweightedaveragepricepersharereissuedPursuantToModification	4.00
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	6682359	shares
CY2021Q4	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding Weighted Average Exercise Price Beginning Balance ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceBeginningBalance	4.32
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2163220	shares
CY2022	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsGrantsInPeriodWeightedAverageExercisePrice	1.99
CY2022	rcrt	Exchanged To Common Stock ExchangedToCommonStock	112726	shares
CY2022	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Grants In Period Exchanged To Common Stock ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsGrantsInPeriodExchangedToCommonStock	5.00
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	11290951	shares
CY2022	rcrt	Increase Due To Trigger Of Anti Dilution Provisions IncreaseDueToTriggerOfAntiDilutionProvisions	2558098	shares
CY2022Q4	rcrt	Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePrice	2.84
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y5M4D
CY2022	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2022	rcrt	Dividend Yield DividendYield	0.0000	pure
CY2021Q4	rcrt	Promissory Note Complainant Amount PromissoryNoteComplainantAmount	500000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Commercial Paper ProceedsFromIssuanceOfCommercialPaper	500000	usd
CY2022Q2	rcrt	Promissory Note Complainant Interest Rate PromissoryNoteComplainantInterestRate	0.12	pure
CY2021Q2	rcrt	Litigation Accrued LitigationAccrued	250000	usd
CY2021Q4	rcrt	Investor Relations Payment InvestorRelationsPayment	253505	usd
CY2022	rcrt	Recognition Of Revenue RecognitionOfRevenue	161904	usd
CY2019Q3	rcrt	Lease Expiration Description LeaseExpirationDescription	The sublease originally was set to expire in November 2022
CY2020Q1	rcrt	Covid19 Description Covid19Description	The extent to which the COVID-19 pandemic will impact operations, ability to obtain financing or future financial results is uncertain at this time
CY2019	rcrt	Description Of Consultant Agreement DescriptionOfConsultantAgreement	The Company has agreed to pay the consultant a retainer of $10,000 per month as a non-recoverable draw against any finder fees earned. The Company has also agreed to pay the consultant the sum of $5,500 per month for three years ($198,000 total) as a finder’s fee for introducing Genesys to the Company
CY2021	rcrt	Consulting Fees Expense ConsultingFeesExpense	13500	usd
CY2022	us-gaap	Regulated Operating Revenue Other RegulatedOperatingRevenueOther	0	usd
CY2021	us-gaap	Regulated Operating Revenue Other RegulatedOperatingRevenueOther	106842	usd
CY2022	us-gaap	Regulated Operating Revenue Other RegulatedOperatingRevenueOther	0	usd
CY2021	rcrt	Employer Of Record Services Costs EmployerOfRecordServicesCosts	99904	usd
CY2022Q4	rcrt	Owes Icon Cost OwesIconCost	0	usd
CY2021Q4	rcrt	Owes Icon Cost OwesIconCost	163672	usd
CY2022Q4	rcrt	Payment Of Icon PaymentOfIcon	0	usd
CY2021Q4	rcrt	Payment Of Icon PaymentOfIcon	49033	usd
CY2022	rcrt	Revenue From Icon RevenueFromIcon	0	usd
CY2021	rcrt	Revenue From Icon RevenueFromIcon	970	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	0	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	22951	usd
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	17745	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	40100000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	7100000	usd
CY2022	rcrt	Deferred Tax Carried Forward DeferredTaxCarriedForward	33000000.0	usd
CY2022	rcrt	Valuation Allowance Percentage ValuationAllowancePercentage	1	pure
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3919000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3272000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8723	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6377	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	375	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	350	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3126	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1717	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	14	usd
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	19	usd
CY2022Q4	rcrt	Deferred Tax Asset Bad Debt Allowance DeferredTaxAssetBadDebtAllowance	376	usd
CY2021Q4	rcrt	Deferred Tax Asset Bad Debt Allowance DeferredTaxAssetBadDebtAllowance	221	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-689	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-942	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	23	usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	241	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11902	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7983	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11902	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7983	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	In general, an ownership change, as defined by Section 382 and 383, results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percentage points over a three-year period. The Company has not completed an IRC Section 382/383 analysis.
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.21	pure
CY2022	rcrt	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1 EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1	-0.210	pure
CY2021	rcrt	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate1 EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate1	-0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0011	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0210	pure
CY2022	rcrt	Effective Income Tax Rate Reconciliation Permanent Differences Overaccruals And Nondeductible Items EffectiveIncomeTaxRateReconciliationPermanentDifferencesOveraccrualsAndNondeductibleItems	0.0582	pure
CY2021	rcrt	Effective Income Tax Rate Reconciliation Permanent Differences Overaccruals And Nondeductible Items EffectiveIncomeTaxRateReconciliationPermanentDifferencesOveraccrualsAndNondeductibleItems	0.0326	pure
CY2022	rcrt	Effective Income Tax Rate Reconciliation True Ups EffectiveIncomeTaxRateReconciliationTrueUps	-0.0850	pure
CY2021	rcrt	Effective Income Tax Rate Reconciliation True Ups EffectiveIncomeTaxRateReconciliationTrueUps	-0.0019	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2379	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2003	pure
CY2022	rcrt	Effective Income Tax Rate EffectiveIncomeTaxRate	0	pure
CY2021	rcrt	Effective Income Tax Rate EffectiveIncomeTaxRate	0	pure

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
rcrt-20221231_cal.xml	Edgar Link	unprocessable
recruiter_10k_htm.xml	Edgar Link	completed
0001654954-23-004101-index-headers.html	Edgar Link	pending
0001654954-23-004101-index.html	Edgar Link	pending
0001654954-23-004101.txt	Edgar Link	pending
0001654954-23-004101-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
rcrt-20221231.xsd	Edgar Link	pending
recruiter_10k.htm	Edgar Link	pending
recruiter_10kimg4.jpg	Edgar Link	pending
recruiter_ex231.htm	Edgar Link	pending
recruiter_ex311.htm	Edgar Link	pending
recruiter_ex312.htm	Edgar Link	pending
recruiter_ex321.htm	Edgar Link	pending
recruiter_ex322.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
rcrt-20221231_def.xml	Edgar Link	unprocessable
rcrt-20221231_lab.xml	Edgar Link	unprocessable
rcrt-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NIXX
Nixxy, Inc. Stock $nixx

2023 Q1 Form 10-K Financial Statement

#000165495423004101 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIXX Nixxy, Inc. Stock $nixx

2023 Q1 Form 10-K Financial Statement

#000165495423004101 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NIXX
Nixxy, Inc. Stock $nixx